A Randomized Controlled Trial of Pretransplant Antiviral Therapy to Prevent Recurrence of Hepatitis C after Liver Transplantation

Hepatitis C virus (HCV) infection recurs in liver recipients who are viremic at transplantation. We conducted a randomized controlled trial to test the efficacy and safety of pre-transplant pegylated interferon alpha-2b plus ribavirin (Peg-IFN-a2b/RBV) for prevention of post-transplant HCV recurrenc...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Everson, Gregory T., Terrault, Norah A., Lok, Anna S., Rodrigo, Del R., Brown, Robert S., Saab, Sammy, Shiffman, Mitchell L., Al-Osaimi, Abdullah M. S., Kulik, Laura M., Gillespie, Brenda W., Everhart, James E.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2013
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3510348/
https://ncbi.nlm.nih.gov/pubmed/22821361
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.25976
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares